Prostate cancer screening has no effect on survival
In a 20 year follow up study screening for prostate cancer was found to have no effect on mortality, reports a Swedish study in the British Medical Journal.
Neither the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial or the European Randomized Study of Screening for Prostate Cancer (ERSPC) have shown unequivocal benefit from prostate specific antigen screening. In 1987 a randomised controlled trial on screening for prostate cancer was started in Norrköping, Sweden, by Gabriel Sandblom and colleagues from the Department of Urology at Norrköping to determine whether screening for prostate cancer reduces prostate specific mortality.
Read the whole article at ecancermedicalscience
Reference
- Sandblom, G., Varenhorst, E., et al. (2011). Randomised prostate cancer screening trial: 20 year follow-up BMJ DOI: 10.1136/bmj.300.6731.1041
Keywords: prostate cancer screening, digital rectal examination, survival
7. 4. 2011 ecancermedicalscience
